RE:RE:RE:RE:RE:RE:For French speaking folks I am reading sources that say the average cost of a Ph3 is $20 mil but also that the average cost per patient is around $40,000. I wonder if Paul is just going on averages. If we just price the first 900 to get to approval it looks like he choose a lower estimate.
SPCEO1 wrote: I am not 100% cetain that what I said is correct. But I do know these trials are expensive and while they may gather 18 months of data, it will take 3-3.5 years to do that. So, given 2,000 patients it is hard to see how that could be accomplished for $20 million.
scarlet1967 wrote: I am a bit baffled, I clearly remember when they announce the general NASH there was a reference to the cost of the trial and they said the 18 months trial will cost about $20 millions now looking at the same PR that reference is gone?
SPCEO1 wrote: I believe it is more like the full $100 million to get the trial to approval. Phase IV costs are on top of that.
scarlet1967 wrote: The $100 millions cost is for combined phase 3 (about 20 $millions) and post approval phase 4(about $80 millions ) if approved they will be commercializing the drug and will be generating revenues already.The sales in Canada can't be 0.
Thao977 wrote: A lot of talk about drug price in Canada. Confirm NASH phase 3 Will start soon. Cost 100 millions No update about oncologie Phase 1. Sale $0 in Canada Interresting but no new info